简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-08-18 15:00 Probiotics for Corals Boost Resilience, Help Prevent Mortality
2021-08-17 08:53 Philip Morris International Enters Tender Period with Vectura Shareholders Following Unanimous Recommendation by Vectura Board
2021-08-13 09:24 Rockley Photonics Announces Successful Closing of Business Combination with SC Health Corp.
2021-08-12 17:37 U.S. Leaders Sign Letter to President Biden to Lead G-7 Effort to Vaccinate Majority of the World’s Population by Year-End
2021-08-12 17:35 SpeeDx Receives Clearance for COVID-19 Diagnostic Test
2021-08-10 18:48 Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics
2021-08-10 11:15 SETi’s Violeds Technology Solution to Support Delta Variant Spreading Prevention
2021-08-09 22:21 Philip Morris International Acquires Inhaled Drug Specialist OtiTopic; Growing Pipeline of “Beyond Nicotine” Inhaled Therapeutic Products
2021-08-06 10:11 Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks
2021-08-06 09:07 Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal™ Dx Lung and Colon Cancer Assay
2021-08-05 20:00 Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal™ Dx Lung and Colon Cancer Assay
2021-08-05 13:22 Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance1
2021-08-05 09:28 ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results from Two on-going Phase 2a Studies in Chronic Hepatitis B Patients
2021-08-03 16:16 First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
2021-08-03 14:03 Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
2021-08-03 11:32 Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
2021-08-03 11:25 Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress
2021-08-03 10:08 LianBio Appoints Pascal Qian as General Manager of China
2021-07-30 22:47 Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
2021-07-29 16:04 PHC Holdings Corporation: Appointment of Mr. Alan Malus and Ms. Kyoko Deguchi as Independent External Directors

Business Wire Weibo

Press Releases

Latest Releases